TrialThe Journal of allergy and clinical immunology2019

Loss of bronchoprotection with ICS plus LABA treatment, β-receptor dynamics, and the effect of alendronate.

Juan Carlos Cardet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.